Published in Cancer Weekly, May 16th, 2000
"Dendritic cells (DC) are professional antigen presenting cells (APC) that can be used for vaccination purposes in order to induce a specific T-cell response in vivo against melanoma-associated antigens," according to A. Mackensen and colleagues from the Freiburg University Medical Center, and the Institute of Molecular Medicine, United Kingdom. "Here we report on immunological responses in melanoma patients induced by vaccination with peptide-pulsed DC generated in vitro from CD34+ hematopoietic progenitor...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.